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Abstract  
Background: Experiences of impossible mechanical ventilation due to laryngeal closure 
immediately after sugammadex injection were reported in patients with supraglottic airway 
device. We tested a hypothesis that injection of sugammadex for complete reversal of rocuronium- 
induced muscle paralysis decreases the vocal cord angle (primary variable) during emergence 
from general anaesthesia. 
Methods: In 10 anaesthetized and paralyzed children undergoing minor surgeries with 
supraglottic airway device, endoscopic vocal cord images were recorded in order to compare the 
vocal cord angle before and after injection of sugammadex during emergence from general 
anaesthesia in addition to respiratory variables. As a no intervention time control group, changes 
of the vocal cord angle during emergence from general anaesthesia were assessed in 10 non- 
paralyzed children. 
Results: The vocal cord angle during expiration and inspiration did not significantly differ before 
and after injection of sugammadex (expiration: 36.4±6.9 to 35.9±5.4 degree, 95% C.I. of 
difference of means -1.9 to 3.0 degree, p = 0.634; inspiration: 36.2±7.1 to 35.8±5.6 degree, 95% 
C.I. of difference of means -1.6 to 2.5 degree, p = 0.638). Differences of expiratory vocal cord 
angle before and after sugammadex injection ranged between -6.5 to 4.7 degree. Multiple linear 
regression analysis identified lower fentanyl effect site concentration before sugammadex 
injection as a single independent risk factor for decreasing the expiratory vocal cord angle after 
injection of sugammadex. No vocal cord angle changes were observed in non-paralyzed children 
during emergence from anaesthesia. 
Conclusions: Sugammadex per se does not narrow the laryngeal airway patency and is to be 
administered under deep anaesthesia level for complete reversal of muscle paralysis in small 
children with supraglottic airway. 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
Insertion of supra glottic airway (SGA) as a conduit during general anaesthesia hsd become a 
standard for airway maintenance even in small children. In comparison to tracheal intubation, 
recent meta-analysis evidenced less incidences of perioperative respiratory complications, such 
as desaturation, laryngospasm, cough and breath holding, in children with SGA during 
anaesthesia1. However, since SGA does not bypass the vocal cords, complications such as 
transient upper airway obstruction and mild stridor without desaturation are often encountered in 
children with SGA during emergence from general anaesthesia, particularly when muscle relaxant 
was not used or completely reversed. Although rare, laryngospasm and severe laryngeal 
narrowing are major respiratory causes of cardiac arrest in pediatric anaesthesia 2. Difficult 
Airway Society extubation guideline recommends complete reversal of muscle relaxant to 
minimize postoperative respiratory complications caused by residual muscle paralysis3. 
Administration of an appropriate dose of sugammadex rapidly and completely restores 
rocuronium-induced muscle paralysis in anaesthetized children4-6. Use of sugammadex is reported 
to be useful for management of children with difficult airways7. No increase of perioperative 
anaphylaxis8 and less emergence agitation incidences9 also support use of sugammadex in 
children. Despite these advantages of sugammadex usage, there have been unaddressed but 
extensive arguments among anaesthesiologists regarding possibility of sugammadex-induced 
laryngospasm particularly in anaesthetized adult patients with SGA mainly based on series of case 
reports and anecdotal evidences10-14. Similar cases with development of severe negative pressure 
pulmonary edema were documented in the literatures15,16. McGuire and Dalton reported 
experiences of airway obstruction and laryngeal closure immediately after SGA exchange with 
Bailey’s manoeuvre in head and neck surgery patients when sugammadex was injected10. They 
further speculated occurrence of sugammadex-induced laryngospasm in previously reported cases 
with difficult airways during anaesthesia induction17,18. No doubt, laryngospasm occurred within 
a few minutes after sugammadex administration in these cases, but airway interventions were also 
performed immediately before administration of sugammadex. To date, it is unclear whether the 
laryngeal closure is caused by sugammadex per se or other mechanisms influencing any part of 
the laryngeal reflex arc such as mechanical airway receptor stimulation, level of anaesthesia and 
consciousness, chemical stimuli, and/or involvement of opioid-induced laryngeal rigidity 19,20. 
Notably, Komasawa et al. tested contribution of consciousness level before sugammadex 
administration to development of laryngospasm implying involvement of non-sugammadex 
mechanisms21. Accordingly, we hypothesized that use of sugammadex for reversal of muscle 
paralysis narrows the laryngeal airway during emergence from general anaesthesia (primary 
hypothesis) and tested it by endoscopically recording changes of the vocal cord angle (primary 
variable) before and after sugammaex injection during emergence from general anaesthesia 
without stimulation of the airway receptors responsible for the reflex arc. This hypothesis was 
tested in the pediatric population in which laryngospasm is of great clinical significance22. 
 
Methods 
Study population 
This prospective hypothesis testing study was performed at Chiba University Hospital, Chiba, 
Japan and approved by Chiba University's Institutional Review Board (IRB #2471) and written 
informed consent was obtained from each of the parent(s) of all children participating in the trial. 
The trial was registered prior to patient enrollment at the UMIN (University Hospital Information 
Network) Clinical Trial Registry (UMIN000025058, Principal investigator: Yuji  Kitamura, 
Date of registration: November 29, 2016, website: https://upload.umin.ac.jp/cgi-open-
bin/ctr_e/ctr_view.cgi?recptno=R000028697). Contact information for the full trial information 
is available at the UMIN website. Inclusion criteria were small children (1 to 6 years old, male 
and female, body weight > 10kg, ASA-PS 1 to 3) undergoing sevoflurane anaesthesia with SGA 
for inguinal hernia surgery and cryptorchidism surgery. Exclusion criteria for children were those 
undergoing emergency surgery, with risk of aspiration, under oxygen therapy, under tubal feeding, 
scheduled for laparoscopic surgery, with coagulation abnormality, with history of larynx disease, 
with history of intubation within one month of birth, taking anti-convulsion drugs, and whom 
SGA does not fit. In addition to the inclusion and exclusion criteria of this study and the surgical 
procedure schedule, an investigator questioned the anaesthetist-in-charge regarding the 
anaesthesia plan in order to confirm the subject’s eligibility for this study. The investigator 
provided no suggestions regarding the anaesthesia plan; however, controlled the total number of 
the children included in the sugammadex group and non-paralyzed group, respectively. The 
investigator fully explained the aim and potential risks of the study to each of the parent(s) of the 
child. The explanation in plain terms was also given to juvenile children based on the judgement 
by the parent(s) and the investigator. Only children whose written informed consent was obtained 
from the parent(s) were enrolled in this study. Enrollment in this prospective study was terminated 
on July 27, 2018. 
 
Preparation of the subjects 
All anaesthesia managements were preplanned; however, according to necessitation, was changed 
immediately before and/or during anaesthesia by the anaesthetists-in-charge with more than 50 
pediatric anaesthesia experience. In order to avoid stormy induction, the anaesthetists made 
maximum efforts through use of preanaesthetic preparations, including oral administration of 
diazepam syrup (0.7mg/kg, maximum 10mg) and parental accompaniment. Slow induction with 
sevoflurane, usually up to 5% or 8%, was performed while watching video-animation and/or 
playing video-game, afterwhich intravenous line was secured. Following injection of 0.01mg/kg 
of atropine (0.1mg minimum and 0.5 mg maximum), 1-2 mg/kg propofol and 1-3 μg/kg fentanyl 
were administered. In accordance with the anaesthesia preplanning, rocuronium was either 
unused (non-paralyzed group) or intravenously injected by 0.6-1.0 mg/kg (sugammadex group). 
No additional rocuronium was administered. Appropriate size of a disposable SGA (AuraGainTM, 
Ambu®, Ballerup, Denmark) was inserted and anaesthesia was maintained by 1-2% sevoflurane 
and 0.2-0.5μg/kg/min remifentanil. Additional fentanyl and propofol were administered when 
necessary. Pressure controlled mechanical ventilation with PEEP was performed during the 
surgery regardless of the use of muscle relaxant. In addition to standard cardiorespiratory 
monitoring such as pulse oximetry, an electrocardiogram, noninvasive blood pressure 
measurement, and side-stream capnometer, neuromuscular function with acceleromyography 
(TOF-Watch; Organon Ireland Ltd., Dublin, Ireland), and bispectral index (BIS® monitor, Aspect 
Medical Systems, Newton, MA) were continuously monitored. A thin endoscope (LF-DP, O.D. 
3.1mm; Olympus, Tokyo, Japan, or F1-9RBS; Pentax, Tokyo, Japan.) connected by a universal 
connector (AP-RV2; Pentax, Japan) for an endoscope camera (PVK-1070; Pentax, Tokyo, Japan) 
and a light generator (EPK-1000; Pentax, Tokyo, Japan) was inserted to visualize the vocal cords 
through an elbow connector to the SGA and sensors for respiratory measurement were attached 
before surgery. Recordings were continuously performed throughout the anaesthesia management. 
Infiltration of local anaesthetic into the incision wound upon completion of the surgery (0.3% 
ropivacaine 0.5ml/kg) was optional. Both sevoflurane and remifentanil were discontinued at the 
end of surgery in both groups, and 2-4 mg/kg sugammadex was administered based on the 
neuromuscular monitoring. SGA was removed when spontaneous breathing became stable, 
regardless of whether the children opened their eyes or not. The children were transferred to the 
inpatient ward after confirmation of stable cardio-respiratory vital signs. 
 
Measurements 
The patient monitor display, camera image of the child, respiratory recordings on a computer 
screen and endoscope video images of the vocal cords were synchronously integrated on a 
simultaneous screen by use of an encoder (MS-NEB 2, Carina, Kobe, Japan) and recorded on a 
hard disk for later detailed analyses (MV-410RGB multiviewer; FOR-A, Tokyo, Japan). Vocal 
cord angle was defined as the angle produced by lines connecting anterior and posterior 
commissures. The vocal cord images during inspiration and expiration corresponding to four 
different timing; immediately after SGA insertion, immediately after completion of the surgery, 
after complete reversal of muscle paralysis, and during stable spontaneous breathing, were 
identified. The angle was measured four times for each image with a computer software (ImageJ; 
National Institutes of Health, Bethesda, MD), and their average value was used for the statistical 
analysis. Using a pharmacokinetics simulator (FUJIFILM Medical Co. Ltd. , Tokyo,Japan), blood 
concentrations of propofol, fentanyl, and remifentanil were obtained for each of these timings. 
Airflow through the SGA was measured by a Fleisch no. 2 pneumotachograph (4719; Hans 
Rudolph, Kansas City, MO) with a differential pressure transducer (TP-603T; Nihon Kohden, 
Tokyo, Japan) attached to the elbow connector. Airway pressure was measured by a small piezo-
resistive silicon pressure sensor (23NB 005G; ICsensors, San Jose, CA). Respiratory sounds were 
continuously recorded by three microphones placed on the chest and neck (MLT201, AD 
Instruments, Bella Vista, Australia) and at the anaesthesia breathing circuit (ECM-SP10, SONY, 
Tokyo, Japan). All respiratory variables were amplified and stored in a computer after digitizing 
the signals (PowerLab; AD Instruments, Bella Vista, Australia). 
 
Sample size calculation and statistical analysis 
There has been no previous studies which measured the vocal cord angle in children with SGA. 
Tanaka et al. previously reported that the vocal cord angle in adult patients with SGA was 36±6 
degree (mean±SD) and 8 degrees reduction resulted in significant increase of laryngeal 
resistance23. In estimating the sample size for this clinical study, we expected that a similar 
reduction of the vocal cord angle would result after complete reversal of muscle paralysis with 
sugammadex. In order to detect the 8 degrees difference before and after sugammadex injection 
with α=0.05 (two tailed) and β= 0.8, the suitable sample size was calculated to be 7 children 
(SigmaPlot 12.0; Systat Software, Point Richmond, CA). To avoid a type 1 error for the primary 
hypothesis, the appropriate sample size was determined to be 10 children for the sugammadex 
group. In order to perform an appropriate group comparison, the same sample size of 10 children 
was also set for the non-paralyzed group. Variables were expressed as mean ± SD for continuous 
variables, and frequencies and proportions for categorical data. Changes of the variables including 
the primary variable, vocal cord angle, before and after sugammadex injection were assessed by 
paired Student’s t test. For group comparison, the variables were compared by the Fisher’s exact 
test or Chi-square test for categorical outcomes, and Student’s t-test for continuous variables. P 
values were two sided, and a value of P < 0.05 was considered statistically significant. These 
group comparisons were planned. After obtaining the results of the primary analyses described 
above, independent explanatory variables were determined by using a multiple linear regression 
analysis for changes of the expiratory vocal cord angle after sugammadex injection in the 
sugammaex group. As pot-hoc analyses with using all children’s data obtained in this study, 
incidence of stridor was determined and contributing factors to changes of vocal cord angle during 
spontaneous inspiration during emergence from anaesthesia were identified by multiple linear 
regression analysis. All statistical analyses were performed using SAS software version 9.4 (SAS 
Institute, Cary, North Carolina, USA) and SigmaPlot 12.0 (Systat Software Inc., Point Richmond, 
CA). 
 
Results 
Parent(s) of twenty-seven 
children gave written informed 
consents to participate in this 
study (Figure 1). Two children 
whom the anaesthetists chose 
total intravenous anaesthesia 
were excluded from this study. 
Out of the fifteen children 
paralyzed with rocuronium under 
sevoflurane anaesthesia, five 
were excluded due to due to 
unsuccessful recording of TOF 
data and complete recovery from 
the paralysis without 
sugammadex. As planned, sample size of 10 children for the respective sugammadex and non-
paralyzed groups successfully completed the study protocol. Children in the sugammadex group 
were younger and smaller than non-paralyzed group (Table 1). No difference was found between 
the groups in surgical and anaesthesia procedures except propofol effect site concentration at 
emergence of spontaneous breathing (Table 2).  
  
  
Examples of experimental recordings 
Figure 2 presents a series of endoscopic images of the vocal cords with respiratory recordings 
immediately after SGA insertion (TOF count 0), immediately after completion of surgery (TOF 
count 1), after complete recovery of muscle paralysis with sugammadex 5.6 mg/kg, and during 
stable spontaneous breathing in 54 months old girl with #2 AuraGain.  
Patency at the vocal cords was maintained throughout the study period. In contrast, as clearly 
shown in Figure 3, significant reduction of expiratory vocal cord angle was observed after reversal 
of muscle par alysis (TOFR 56% to 99%) with sugammadex 2.7 mg/kg in 41 months old boy with 
#2 AuraGain. Notably, reduction of peak inspiratory airflow resulted in reduction of the tidal 
volume from 170 ml to 125 ml in this child after sugammadex injection although no desaturation 
occurred after sugammadex injection. 
 
 
  
 
  
Results of the primary hypothesis and analysis  of independent risk factors: changes of vocal 
cord angle (primary variable) after sugammadex injection 
Vocal cord angles varied among the children both in sugammadex and non-paralyzed groups with 
similar standard deviations to those previously reported in adults (Table3)23. As a group, vocal 
cord angle both during expiration and inspiration did not significantly differ before and after 
injection of sugammadex for rocuronium-induced muscle paralysis (expiration: 36.4±6.9 to 
35.9±5.4 degree, 95% C.I. of difference of means -1.9 to 3.0 degree, p = 0.634; inspiration: 
36.2±7.1 to 35.8±5.6 degree, 95% C.I. of difference of means -1.6 to 2.5 degree, p = 0.638). 
Accordingly, the primary hypothesis of this study was not supported. However, differences of 
expiratory vocal cord angle before and after sugammadex injection ranged between -6.5 to 4.7 
degree. Multiple linear regression analysis identified a single independent risk factor, i.e. fentanyl 
effect site concentration before sugammadex injection, for changes of the vocal cord angle at the 
expiratory phase after injection of sugammadex as illustrated by Figure 4.  
 
 
 
  
  
 
Surgical influences on vocal cord angle: post-hoc comparison between sugammadex and non-
paralyzed groups 
 Compared to the vocal cord angle before surgery, patent vocal cord angles were maintained 
throughout the surgeries during both respiratory phases in both groups (Table 3). However, the 
expiratory vocal cord angle tended to narrow during surgery in the paralyzed sugammadex group 
while tended to widen during surgery in the non-paralyzed group, resulting in a statistically 
significant difference of the expiratory vocal cord angle changes between the groups as illustrated 
in Figure 5. 
  
 Incidence of stridor and its independent risk factors 
Although the anaesthetists did not recognize inspiratory stridor occurrence based on patient 
monitors and clinical symptoms, such as audible stridor sounds, apparent vocal cord narrowing 
accompanied with stridor sounds detected by microphones was observed after recovery of 
spontaneous breathing in 5 children (25%: 2 in sugammadex group and 3 in non-paralyzed group) 
as clearly demonstrated in Figure 6. The stridor occurred at onset of initial breathing prolonging 
for less than 5 minutes, and disappeared spontaneously.  
Compared to children without stridor (n=15), vocal cord angle of children with stridor 
significantly decreased during inspiration while expiratory vocal cord angle did not differ between 
them (Figure 7). 
  
 Discussions 
This prospective observation study demonstrated that 1) injection of sugammadex for 
rocuronium-induced muscle paralysis did not significantly alter the vocal cord angle in 
anaesthetized children with SGA, 2) lower fentanyl effect site concentration was an independent 
risk factor for laryngeal narrowing after sugammadex injection, 3) vocal cord angle decreased 
during surgery in children with muscle paralysis, 4) stridor immediately after spontaneous 
breathing recovery was common (25%) and temporal, and the incidence was not associated with 
use of sugammadex use. 
 
Effects of sugammadex on laryngeal patency 
The results of this study did not support our primary hypothesis that use of sugammadex for 
reversal of muscle paralysis narrows the laryngeal airway during emergence from general 
anaesthesia as a group comparison. Very interestingly, lower fentanyl effect site concentration 
independently explained vocal cord narrowing after sugammadex injection, although this does 
not directly indicate that sugammadex molecules per se induce laryngeal narrowing in patients 
receiving less opioid during anaesthesia. In general, laryngeal patency is determined by balance 
of forces between the abductor and adductor muscles. Either laryngeal reflex or abrupt recovery 
of laryngeal muscles is considered to be possible mechanisms for laryngeal closure after 
sugammadex injection in previously reported cases10-14. Induction of laryngeal reflex need 
afferent stimuli such as extrinsic mechanical or chemical stimulation of the airway mucosal 
receptors19. In this study, an endoscope was kept within the SGA which avoided mechanical 
airway receptor stimulation. Intravenous injection of particular substances such as capsaicin and 
acetaldehyde are reported to elicit laryngeal reflex through dose-dependent humoral stimulation 
of the lung C and/or J receptors24,25. Injected sugammadex is capable of stimulating these 
receptors, although the vocal cord narrowing was not sugammadex dose-dependent. Accordingly, 
sugammadex-induced laryngeal reflex is unlikely, consequently, we rather speculate that abrupt 
restoration of muscle tonus with sugammadex occurs earlier in the adductor muscles, major tonic 
laryngeal muscles, than the abductor muscle resulting in laryngeal narrowing particularly under 
light anaesthesia while spontaneous slow recovery from muscle paralysis occurs first in the 
abductor muscle, followed by laryngeal adductors 23. In either mechanism, our results suggest that 
higher fentanyl effect site concentration prevents laryngeal narrowing in accordance with 
previous works demonstrating that fentanyl dose-dependent depression of laryngeal reflexes both 
in anaesthetized adults and children27,28, and upper airway muscle activity29 These speculations 
need to be tested in future RCT studies, under control of potential confounders such as fentanyl 
dose, anaesthesia depth and mode of sugammadex administration. 
 
Surgical effects on laryngeal patency 
Our previous study demonstrated a significant decrease of the vocal cord angle and increase of 
laryngeal resistance even after minor surgery particularly in adult patients managed with tracheal 
intubation under general anaesthesia and paralysis 23 Notably, small but significant increase of 
laryngeal resistance was also observed after surgery in patients managed with SGA in this study 
while change of the vocal cord angle was not statistically significant. Furthermore, a decrease of 
the vocal cord angle during surgery was found in children with muscle paralysis (sugammadex 
group) in accordance with the previous study, whereas an increase of the vocal cord angle during 
surgery was evident in children without muscle paralysis (non-paralyzed group). It is considered 
that relative narrowing of the vocal cord immediately after SGA insertion in the non-paralyzed 
group, was possibly due to greater adductor muscle activity over abductor muscle, and therefore, 
increase of the vocal cord angle after surgery does not indicate active dilation of the vocal cord 
during surgery in non-paralyzed children. 
 
Laryngeal behavior during stridor 
To our knowledge, this is the first study which demonstrates a relatively high incidence of 
stridor immediately after recovery of spontaneous breathing during emergence from general 
anaesthesia in small children while stridor persisted only for less than five minutes. Although 
the mechanisms and clinical significance of stridor development are not fully understood, our 
results suggest that sugammadex injection is unlikely to be involved in the mechanisms. Notably, 
stridor was not audible to the anaesthetist’s ears, however detectable through microphones, 
particularly when the microphone was placed in the breathing circuit. As clinical usefulness of 
the microphone on the neck for respiratory rate monitor is evident30, the respiratory sound 
monitoring for diagnosing breathing abnormalities would be of great clinical significance and to 
be developed in the near future. 
 
Limitations of the study 
Our study has several methodological limitations due to nature of the clinical study design. First, 
injection of sugammadex was not blinded which possibly lead to a bias in vocal cord 
measurements. Second, confounding factors, which may have possibly influenced the vocal cord 
angle such anaesthesia depth, opioid dose, and end-tidal CO2 level were not controlled in this 
study, since our intent was to mimic the clinical situation where all confounding factors 
dynamically change during emergence of anaesthesia. Third, population of this study was limited 
to small children less than 6 years old with body weight greater than 10kg whereas sugammadex-
induced laryngospasm occurred only in adult cases. Considering differences of respiratory control 
system between adults and small children, results of this study would not be applicable to adults 
and neonates. Because of these methodological limitations, future randomized controlled studies 
should test the hypothesis by controlling the possible confounding factors particularly the opioid 
effect site concentration both in adults and children. 
 
In conclusion, sugammadex per se does not narrow the laryngeal airway patency and is to be 
administered under deep anaesthesia level for complete reversal of muscle paralysis in small 
children with supraglottic airway. 
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